WANA (Nov 17) – For the first time, Iranian researchers from a knowledge-based company, supported by the Innovation and Prosperity Fund, have developed a portable blood hemoglobin measurement device. This high-tech medical device, previously reliant on imports, places Iran among the few global producers in this field.

 

The lightweight device, weighing just 320 grams, delivers highly accurate results within 15 seconds. Designed for use in blood donation centers, thalassemia clinics, operating rooms, ICUs, and ambulances, it meets international standards and serves as a critical tool in healthcare.

 

According to the company’s CEO, Mohammad Ali Ansari, the idea originated from the unmet needs of organizations like the Iranian Blood Transfusion Organization. Previously, only German and Swedish companies manufactured similar devices. The COVID-19 pandemic and rising import costs highlighted the urgency for domestic production.

 

Currently, the device meets one-third of Iran’s annual demand of four million kits, saving $1.6 million in foreign currency. Plans are underway to increase production, eliminate dependency on imports, and explore international markets after securing certifications such as CE.

 

The company employs 40 experts, many of whom are university graduates and top talents. Despite challenges like funding gaps, skepticism about locally produced goods, and brain drain, the team remains committed to advancing Iran’s medical technology sector.

 

Ansari emphasized the critical role of innovation funds in supporting startups and highlighted the need for policies that nurture and retain domestic talent. “By fostering a sense of purpose and value for our experts, we can keep them in the country and drive further innovation,” he said.